**Core Concept**
Vaginal adenosis is a rare condition characterized by the presence of glandular epithelium in the vagina. This condition is often associated with exposure to diethylstilbestrol (DES) in utero, a synthetic estrogen that was previously prescribed to pregnant women to prevent miscarriage and premature labor.

**Why the Correct Answer is Right**
The use of DES in utero has been linked to the development of vaginal adenosis, as well as other reproductive tract abnormalities. DES is a potent estrogen that can disrupt normal fetal development, leading to the formation of glandular epithelium in the vagina. This is thought to occur due to the abnormal differentiation of mesenchymal cells into glandular epithelial cells, which is a result of the estrogenic stimulation.

**Why Each Wrong Option is Incorrect**
**Option A:** There is no evidence to suggest that exposure to diethylstilbestrol (DES) in utero is associated with vaginal adenosis, making this option incorrect.
**Option B:** While certain infections can cause changes in the vaginal epithelium, there is no direct link between these infections and vaginal adenosis.
**Option C:** Exposure to other hormones or chemicals in utero may have different effects on fetal development, but there is no specific link to vaginal adenosis.

**Clinical Pearl / High-Yield Fact**
Vaginal adenosis is a rare condition that is often associated with exposure to diethylstilbestrol (DES) in utero. It is essential for healthcare providers to take a thorough medical history, including questions about past exposure to DES, to identify patients at risk for this condition.

**Correct Answer:** D.